| Announce Date | 12/03/2025 |
| EPS Normalized Actual | $0.594 (Miss by $-0.306) |
| EPS GAAP Actual | $0.594 (Miss by $-0.306) |
| Revenue Actual | $0.322164B |
| Revenue Surprise | Beat by $322.164M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.93463 |
| EPS GAAP Estimate | $0.93463 |
| Revenue Estimate | $0.34758213B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2028 | 5.45 | 14.38 | 5.34328 | 5.56028 | 2 |
| Jan 2027 | 2.08 | 37.68 | 1.72974 | 2.71405 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.6 | -0.32392 | 0.322164B | 6.75% | -5.71M |
| FQ3 2025 (Jul 2025) | 0.69 | 0.69 | 0.325835B | 7.95% | 325.84M |
| FQ2 2025 (Apr 2025) | 0.62 | 0.62 | 0.330844B | 13.07% | 330.84M |
| FQ1 2025 (Jan 2025) | 0.3 | 0.3 | 0.311817B | 15.85% | 311.82M |
| FQ4 2024 (Oct 2024) | 0.0654 | 0.0654 | 0.300432B | 17.05% | 300.43M |
| FQ3 2024 (Jul 2024) | 0.41 | 0.41 | 0.299928B | 18.8% | 299.93M |
| FQ2 2024 (Apr 2024) | 0.33 | 0.33 | 0.287597B | 15.01% | 287.6M |
| FQ1 2024 (Jan 2024) | 0.31 | 0.31 | 0.262387B | 10.88% | 262.39M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
0.93463
Consensus Revenue Estimates
0.34758213B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 0 | -- | 0 | 0 | 10 |
| FQ4 2027 (Oct 2027) | 0 | -- | 0 | 0 | 5 |
| FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 3 |
| FQ2 2027 (Apr 2027) | 0 | -- | 0 | 0 | 3 |
| FQ1 2027 (Jan 2027) | 0 | -- | 0 | 0 | 8 |
| FQ4 2026 (Oct 2026) | 0 | -INF | 0 | 0 | 5 |
| FQ3 2026 (Jul 2026) | 0 | -INF | 0 | 0 | 3 |
| FQ2 2026 (Apr 2026) | 0 | -INF | 0 | 0 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 0.39B | -- | 0.38B | 0.4B | 5 |
| FQ4 2027 (Oct 2027) | 0.4B | -- | 0.38B | 0.4B | 5 |
| FQ3 2027 (Jul 2027) | 0.4B | -- | 0.38B | 0.4B | 5 |
| FQ2 2027 (Apr 2027) | 0.4B | -- | 0.39B | 0.41B | 5 |
| FQ1 2027 (Jan 2027) | 0.38B | -- | 0.37B | 0.39B | 5 |
| FQ4 2026 (Oct 2026) | 0.37B | 11.79 | 0.36B | 0.37B | 6 |
| FQ3 2026 (Jul 2026) | 0.37B | 10.83 | 0.36B | 0.37B | 4 |
| FQ2 2026 (Apr 2026) | 0.36B | 8.93 | 0.36B | 0.37B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.92392 | 0.6 | -0.32392 | -53.99% |
| FQ3 2025 (Jul 2025) | 0.69 | 0.69 | 100% | |
| FQ2 2025 (Apr 2025) | 0.62 | 0.62 | 100% | |
| FQ1 2025 (Jan 2025) | 0.3 | 0.3 | 100% | |
| FQ4 2024 (Oct 2024) | 0.0654 | 0.0654 | 100% | |
| FQ3 2024 (Jul 2024) | 0.41 | 0.41 | 100% | |
| FQ2 2024 (Apr 2024) | 0.33 | 0.33 | 100% | |
| FQ1 2024 (Jan 2024) | 0.31 | 0.31 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.33B | $0.32B | $-5.71M | -1.77% |
| FQ3 2025 (Jul 2025) | $0B | $0.33B | $325.84M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $0.33B | $330.84M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $0.31B | $311.82M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0.3B | $300.43M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.3B | $299.93M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.29B | $287.6M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.26B | $262.39M | 100% |